152 related articles for article (PubMed ID: 38386672)
1. Quantitative detection and prognostic value of antibodies against M-type phospholipase A2 receptor and its cysteine-rich ricin domain and C-type lectin domains 1 and 6-7-8 in patients with idiopathic membranous nephropathy.
Liu X; Xue J; Li T; Wu Q; Sheng H; Yang X; Lin B; Zhou X; Qin Y; Huang Z; Zhou L; Wang L; Hu Z; Huang B
PLoS One; 2024; 19(2):e0298269. PubMed ID: 38386672
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of the domain specific PLA2R antibodies for clinical remission in patients with primary membranous nephropathy: A retrospective study.
Zhou K; Zhou J; Zhou L; Xue J; Liu B; Zhang Z; Zhang X; Cai T; Shao S; Huang B; Zhang Y; Hu Z; Wang L; Liu X
PLoS One; 2024; 19(5):e0302100. PubMed ID: 38718066
[TBL] [Abstract][Full Text] [Related]
3. PLA2R-IgG4 antibody as a predictive biomarker of treatment effectiveness and prognostic evaluation in patients with idiopathic membranous nephropathy: a retrospective study.
Huang Y; Zhou J; Zhou K; Huang B; Xue J; Zhang X; Liu B; Zhang Z; Zhou L; Cai T; Zhang Y; Hu Z; Wang L; Liu X
PeerJ; 2022; 10():e14193. PubMed ID: 36248712
[TBL] [Abstract][Full Text] [Related]
4. Quantitative detection of anti-PLA2R antibodies targeting different epitopes and its clinical application in primary membranous nephropathy.
Qin Y; Wu Q; Sheng H; Li T; Liu X; Yang X; Lin B; Zhou X; Jin J; Wang L; Huang B; He Q; Hu Z
Clin Chem Lab Med; 2023 Jan; 61(2):251-259. PubMed ID: 36351699
[TBL] [Abstract][Full Text] [Related]
5. Establishment and application of an immunoassay for the simultaneous detection of IgG and its subtype IgG4 autoantibodies against M-type phospholipase A2 receptor.
Li T; Wu Q; Yang X; Zhang Y; Zhou X; Sheng H; Wang Y; Zhang Q; Liu X; Qin Y; Huang B; Wang L; He Q; Hu Z
Clin Biochem; 2021 Oct; 96():49-55. PubMed ID: 34252448
[TBL] [Abstract][Full Text] [Related]
6. Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy.
Kao L; Lam V; Waldman M; Glassock RJ; Zhu Q
J Am Soc Nephrol; 2015 Feb; 26(2):291-301. PubMed ID: 25205735
[TBL] [Abstract][Full Text] [Related]
7. Clinical Evaluation of Antiphospholipase A2 Receptor IgG4 level and Its IgG4-to-IgG Ratio Based on Quantitative Immunoassays in Idiopathic Membranous Nephropathy.
Zhang Y; Huang Y; Huang B; Chen X; Zhou B; Zou P; Wang L; Liu X; Sheng H; Xie M
Biomed Res Int; 2022; 2022():9127520. PubMed ID: 35782060
[TBL] [Abstract][Full Text] [Related]
8. Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy.
Seitz-Polski B; Dolla G; Payré C; Girard CA; Polidori J; Zorzi K; Birgy-Barelli E; Jullien P; Courivaud C; Krummel T; Benzaken S; Bernard G; Burtey S; Mariat C; Esnault VL; Lambeau G
J Am Soc Nephrol; 2016 May; 27(5):1517-33. PubMed ID: 26567246
[TBL] [Abstract][Full Text] [Related]
9. Phospholipase A2 Receptor Antibody IgG4 Subclass Improves Sensitivity and Specificity in the Diagnosis of Idiopathic Membranous Nephropathy.
Huang B; Zhang Y; Wang L; Xu W; Zhang J; Zhang Q; Sheng H; Hu Z
Kidney Blood Press Res; 2019; 44(4):848-857. PubMed ID: 31242492
[TBL] [Abstract][Full Text] [Related]
10. Structural determinants of the dominant conformational epitopes of phospholipase A2 receptor in primary membranous nephropathy.
Tang H; Zhu R; Waldman M; Zhu Q
J Biol Chem; 2022 Mar; 298(3):101605. PubMed ID: 35065076
[TBL] [Abstract][Full Text] [Related]
11. Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy.
Fresquet M; Jowitt TA; Gummadova J; Collins R; O'Cualain R; McKenzie EA; Lennon R; Brenchley PE
J Am Soc Nephrol; 2015 Feb; 26(2):302-13. PubMed ID: 25288605
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study.
Xie Z; Dong W; Li Z; Chen Y; Song L; Li R; Wu Y; Fu L; Liang H; Tao Y; Xie J; Wang W; Liu S; Ye Z; Shi W; Liang X
Nephrology (Carlton); 2020 Mar; 25(3):219-229. PubMed ID: 31900967
[TBL] [Abstract][Full Text] [Related]
13. A PLA2R-IgG4 Antibody-Based Predictive Model for Assessing Risk Stratification of Idiopathic Membranous Nephropathy.
Liu X; Xue J; Guo X; Ding Y; Zhang Y; Zhang X; Huang Y; Huang B; Hu Z; Lu G; Wang L
J Healthc Eng; 2021; 2021():1521013. PubMed ID: 34512932
[TBL] [Abstract][Full Text] [Related]
14. Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy.
Liu L; Chang B; Wu X; Guo Y; Pan Y; Yang L
Vasc Health Risk Manag; 2018; 14():103-108. PubMed ID: 29881283
[TBL] [Abstract][Full Text] [Related]
15. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study.
Zhao Y; Cai M; Jiang Z; Dong B; Yan Y; Wang Y; Zuo L
Ren Fail; 2022 Dec; 44(1):428-433. PubMed ID: 35272568
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Glomerular IgG Subclasses Switch in Idiopathic Membranous Nephropathy Classified by Glomerular Phospholipase A2 Receptor Antigen and Serum Antibody.
Cui HY; Li C; Li H; Wen YB; Duan L; Li Y; Yan XW; Hu YT; Chen LM; Li XM
Dis Markers; 2021; 2021():9965343. PubMed ID: 34497677
[TBL] [Abstract][Full Text] [Related]
17. [Clinical Significance of IgG4 Level in Predicting the Activity and Outcome of Phospholipase A2 Receptor-associated Membranous Nephropathy].
DU YY; Jiang X; Wang WR; Tang XL; Sun Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):579-584. PubMed ID: 36065689
[TBL] [Abstract][Full Text] [Related]
18. Phospholipase A2 Receptor Antibodies and Clinical Prognosis in Patients with Idiopathic Membranous Nephropathy: An Updated Systematic Review and Meta-Analysis.
Zhang J; Fan Z; Wang P; Zhang AH
Kidney Blood Press Res; 2023; 48(1):102-113. PubMed ID: 36720217
[TBL] [Abstract][Full Text] [Related]
19. Clinical Predictive Value of Phospholipase A2 Receptor Gene Polymorphism Combined with Subclass of Immunoglobulin G in Renal Tissues for Membranous Nephropathy.
Ji C; Xu Q; Bian X
Altern Ther Health Med; 2023 Oct; 29(7):418-423. PubMed ID: 37535917
[TBL] [Abstract][Full Text] [Related]
20. Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy.
Tian C; Li L; Liu T; Qu X; Qiu Y
Int Urol Nephrol; 2019 Aug; 51(8):1371-1377. PubMed ID: 31227982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
